Ethics: Investigators' interests: what should trial participants be told?
Minimizing the potential adverse effects of clinical investigators' financial conflicts of interest involves, in part, determining how much of an investigator's "business" should be disclosed to participants in research studies. What should be disclosed and why? How will we know if disclosure matters?
Romain
Paul L
PL
Division of Rheumatology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA. promain@bidmc.harvard.edu
D035843:Biomedical Research / Q000941:ethics; D002986:Clinical Trials as Topic / Q000941:ethics*; D016265:Conflict of Interest; D030881:Disclosure; D006801:Humans